\-\ Texto\\:\\ \ \(0\)\
\-\ pe\\:\\ left\\ hip\\ is\\ held\\ flexed\\,\\ abducted\\,\\ externally\\ rotated\\.\ \(0\)\
\-\ labs\\:\\ normal\\ crp\\,\\ esr\\,\\ wbc\\.\ \(0\)\
\-\ nsaids\\ may\\ shorten\\ the\\ duration\\ of\\ symptoms\\.\\ \ \(0\)\
\-\ patients\\ with\\ ts\\ usually\\ experience\\ marked\\ improvement\\ within\\ 24\\-48\\ hours\\.\\ two\\ thirds\\ to\\ three\\ fourths\\ of\\ patients\\ with\\ ts\\ have\\ complete\\ resolution\\ within\\ 2\\ weeks\\.\\ the\\ remainder\\ may\\ have\\ less\\-severe\\ symptoms\\ for\\ several\\ weeks\\.\ \(0\)\
\-\ the\\ recurrence\\ rate\\ is\\ 4\\-17\\%\\;\\ most\\ recurrences\\ develop\\ within\\ 6\\ months\ \(0\)\
\-\ if\\ significant\\ symptoms\\ persist\\ for\\ 7\\-10\\ days\\ after\\ the\\ initial\\ presentation\\,\\ consider\\ other\\ diagnoses\\.\\ \ \(0\)\
\-\ advise\\ that\\ all\\ patients\\ with\\ ts\\ have\\ repeat\\ radiographs\\ within\\ 6\\ months\\ to\\ exclude\\ lcp\\ disease\\.\ \(0\)\
\-\ ultrasound\\ of\\ the\\ hips\\ demonstrates\\ a\\ left\\-sided\\ hip\\ effusion\\ measuring\\ approximately\\ \\ 2\\.9\\ cm\\ \\(cc\\)\\ x\\ 0\\.8\\ cm\\ \\(trv\\)\\,\\ asymmetric\\ when\\ compared\\ to\\ the\\ right\\ hip\\.\\ the\\ joint\\ fluid\\ demonstrates\\ diffuse\\ low\\ level\\ echoes\\.\ \(0\)\
\-\ transient\\ synovitis\\ of\\ the\\ hip\ \(0\)\
\-\ 1\\.\\ \\ septic\\ arthritis\ \(0\)\
\-\ 2\\.\\ \\ transient\\ synovitis\ \(0\)\
\-\ 3\\.\\ \\ juvenile\\ ra\ \(0\)\
\-\ 4\\.\\ \\ malignancy\\ \\(leukemia\\)\ \(0\)\
\-\ 5\\.\\ \\ sickle\\ cell\\ anemia\ \(0\)\
\-\ 6\\.\\ \\ legg\\-calve\\-perthes\\ \\(lcp\\)\\ disease\ \(0\)\
\-\ 7\\.\\ \\ fracture\ \(0\)\
\-\ 8\\.\\ \\ soft\\ tissue\\ injury\ \(0\)\
\-\ 5\\ year\\ old\\ female\\ with\\ new\\ unilateral\\ left\\ hip\\ pain\\ with\\ limp\\.\\ low\\ grade\\ fever\\.\\ antecedent\\ uri\\ 5\\ weeks\\ prior\\.\\ no\\ known\\ trauma\\.\ \(0\)\
\-\ recent\\ history\\ of\\ upper\\ respiratory\\ infection\\ \\(pharyngitis\\,\\ bronchitis\\,\\ otitis\\ media\\)\\ elicited\\ in\\ approximately\\ 50\\%\\ of\\ patients\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ ts\\:\\ 0\\.08244219406294244\ \(0\)\
\-\ hip\\:\\ 0\\.07181165342007295\ \(0\)\
\-\ lcp\\:\\ 0\\.06854321724393715\ \(0\)\
\-\ synovitis\\:\\ 0\\.0443896233120429\ \(0\)\
\-\ transient\\:\\ 0\\.03903682432016938\ \(0\)\
\-\ patients\\:\\ 0\\.0373261535757979\ \(0\)\
\-\ fourths\\:\\ 0\\.037196280269900836\ \(0\)\
\-\ less\\-severe\\:\\ 0\\.037196280269900836\ \(0\)\
\-\ 4\\-17\\:\\ 0\\.037196280269900836\ \(0\)\
\-\ shorten\\:\\ 0\\.034271608621968576\ \(0\)\
\-\ advise\\:\\ 0\\.032560785381005854\ \(0\)\
\-\ abducted\\:\\ 0\\.031346936974036316\ \(0\)\
\-\ weeks\\:\\ 0\\.030699718441786688\ \(0\)\
\-\ antecedent\\:\\ 0\\.029636113733073597\ \(0\)\
\-\ pharyngitis\\:\\ 0\\.02898568892367588\ \(0\)\
\-\ held\\:\\ 0\\.02792529049211088\ \(0\)\
\-\ 7\\-10\\:\\ 0\\.02792529049211088\ \(0\)\
\-\ within\\:\\ 0\\.027512766386262977\ \(0\)\
\-\ externally\\:\\ 0\\.02707857869691193\ \(0\)\
\-\ thirds\\:\\ 0\\.02707857869691193\ \(0\)\
\-\ recurrences\\:\\ 0\\.02707857869691193\ \(0\)\
\-\ trv\\:\\ 0\\.02707857869691193\ \(0\)\
\-\ symptoms\\:\\ 0\\.0269576895809891\ \(0\)\
\-\ 24\\-48\\:\\ 0\\.026711442085141337\ \(0\)\
\-\ legg\\-calve\\-perthes\\:\\ 0\\.026711442085141337\ \(0\)\
\-\ bronchitis\\:\\ 0\\.026061017275743625\ \(0\)\
\-\ 2\\.9\\:\\ 0\\.025769908113351423\ \(0\)\
\-\ uri\\:\\ 0\\.0254975936781718\ \(0\)\
\-\ flexed\\:\\ 0\\.024772487108861003\ \(0\)\
\-\ 0\\.8\\:\\ 0\\.02415390704897967\ \(0\)\
\-\ echoes\\:\\ 0\\.0239663468693559\ \(0\)\
\-\ limp\\:\\ 0\\.0239663468693559\ \(0\)\
\-\ otitis\\:\\ 0\\.02361452573459197\ \(0\)\
\-\ have\\:\\ 0\\.023423266814747996\ \(0\)\
\-\ rotated\\:\\ 0\\.023289795603215903\ \(0\)\
\-\ persist\\:\\ 0\\.023289795603215903\ \(0\)\
\-\ media\\:\\ 0\\.02298828098725748\ \(0\)\
\-\ elicited\\:\\ 0\\.022845236465419163\ \(0\)\
\-\ approximately\\:\\ 0\\.02231069895827496\ \(0\)\
\-\ crp\\:\\ 0\\.02207594719624636\ \(0\)\
\-\ 6\\:\\ 0\\.021536878998944086\ \(0\)\
\-\ diagnoses\\:\\ 0\\.021326237587649514\ \(0\)\
\-\ hips\\:\\ 0\\.02122923540104741\ \(0\)\
\-\ 5\\:\\ 0\\.02109840018940222\ \(0\)\
\-\ 8\\.\\:\\ 0\\.020136992219966024\ \(0\)\
\-\ low\\:\\ 0\\.020052051079041344\ \(0\)\
\-\ sickle\\:\\ 0\\.01992056481748691\ \(0\)\
\-\ experience\\:\\ 0\\.01978221113468948\ \(0\)\
\-\ ra\\:\\ 0\\.01971469914588593\ \(0\)\
\-\ months\\:\\ 0\\.019695707128186222\ \(0\)\
\-\ juvenile\\:\\ 0\\.019648250382307282\ \(0\)\
\-\ consider\\:\\ 0\\.01958283187371671\ \(0\)\
\-\ nsaids\\:\\ 0\\.019454961200740643\ \(0\)\
\-\ cm\\:\\ 0\\.01934140183811802\ \(0\)\
\-\ cc\\:\\ 0\\.01933085198046092\ \(0\)\
\-\ 7\\.\\:\\ 0\\.019210289227532415\ \(0\)\
\-\ exclude\\:\\ 0\\.019151275548314105\ \(0\)\
\-\ duration\\:\\ 0\\.01909307587686965\ \(0\)\
\-\ septic\\:\\ 0\\.018923143812996486\ \(0\)\
\-\ leukemia\\:\\ 0\\.018500850738916386\ \(0\)\
\-\ esr\\:\\ 0\\.01825688630478632\ \(0\)\
\-\ develop\\:\\ 0\\.01798160984120657\ \(0\)\
\-\ anemia\\:\\ 0\\.017937427141344563\ \(0\)\
\-\ unilateral\\:\\ 0\\.01789370230153213\ \(0\)\
\-\ left\\-sided\\:\\ 0\\.01776518243872745\ \(0\)\
\-\ asymmetric\\:\\ 0\\.017519322066896333\ \(0\)\
\-\ 6\\.\\:\\ 0\\.017519322066896333\ \(0\)\
\-\ remainder\\:\\ 0\\.01699589316955465\ \(0\)\
\-\ repeat\\:\\ 0\\.016960877123923024\ \(0\)\
\-\ improvement\\:\\ 0\\.01682364846693754\ \(0\)\
\-\ \\%\\:\\ 0\\.01682127454300428\ \(0\)\
\-\ pe\\:\\ 0\\.016197403719603053\ \(0\)\
\-\ may\\:\\ 0\\.015817117037114966\ \(0\)\
\-\ demonstrates\\:\\ 0\\.015752077651081737\ \(0\)\
\-\ recurrence\\:\\ 0\\.015729629066388667\ \(0\)\
\-\ resolution\\:\\ 0\\.015551138012841454\ \(0\)\
\-\ 5\\.\\:\\ 0\\.015551138012841454\ \(0\)\
\-\ arthritis\\:\\ 0\\.015403934388367022\ \(0\)\
\-\ compared\\:\\ 0\\.015261693640087226\ \(0\)\
\-\ \\(\\:\\ 0\\.01523969886590423\ \(0\)\
\-\ \\)\\:\\ 0\\.015053537808297575\ \(0\)\
\-\ respiratory\\:\\ 0\\.014969030653599873\ \(0\)\
\-\ measuring\\:\\ 0\\.014419222457589642\ \(0\)\
\-\ 4\\.\\:\\ 0\\.014196118018568765\ \(0\)\
\-\ hours\\:\\ 0\\.01417804771564893\ \(0\)\
\-\ marked\\:\\ 0\\.01407122152162239\ \(0\)\
\-\ rate\\:\\ 0\\.014053677175003556\ \(0\)\
\-\ malignancy\\:\\ 0\\.01393286783882496\ \(0\)\
\-\ grade\\:\\ 0\\.013733488577852193\ \(0\)\
\-\ 50\\:\\ 0\\.01371729120946753\ \(0\)\
\-\ effusion\\:\\ 0\\.013701155781457388\ \(0\)\
\-\ wbc\\:\\ 0\\.01314377574082621\ \(0\)\
\-\ complete\\:\\ 0\\.012689349932430607\ \(0\)\
\-\ new\\:\\ 0\\.012564506231225984\ \(0\)\
\-\ labs\\:\\ 0\\.01253997471280649\ \(0\)\
\-\ presentation\\:\\ 0\\.012419411959877984\ \(0\)\
\-\ 3\\.\\:\\ 0\\.012337021992154966\ \(0\)\
\-\ fever\\:\\ 0\\.012199420365198168\ \(0\)\
\-\ three\\:\\ 0\\.012154532609058693\ \(0\)\
\-\ recent\\:\\ 0\\.012121177421264966\ \(0\)\
\-\ initial\\:\\ 0\\.011947603980081467\ \(0\)\
\-\ x\\:\\ 0\\.011894794663913405\ \(0\)\
\-\ disease\\:\\ 0\\.01178681469380341\ \(0\)\
\-\ joint\\:\\ 0\\.011660039050810467\ \(0\)\
\-\ several\\:\\ 0\\.011591109011486866\ \(0\)\
\-\ injury\\:\\ 0\\.011494550809657384\ \(0\)\
\-\ 2\\.\\:\\ 0\\.01146600903713189\ \(0\)\
\-\ radiographs\\:\\ 0\\.011418864308869757\ \(0\)\
\-\ known\\:\\ 0\\.011409498246682782\ \(0\)\
\-\ 1\\.\\:\\ 0\\.011262401545559497\ \(0\)\
\-\ days\\:\\ 0\\.011050946397350115\ \(0\)\
\-\ usually\\:\\ 0\\.010949064362307\ \(0\)\
\-\ diffuse\\:\\ 0\\.010915643123946476\ \(0\)\
\-\ ultrasound\\:\\ 0\\.010696719767959084\ \(0\)\
\-\ infection\\:\\ 0\\.010481082591024501\ \(0\)\
\-\ level\\:\\ 0\\.01039193682551448\ \(0\)\
\-\ two\\:\\ 0\\.010326292141839685\ \(0\)\
\-\ when\\:\\ 0\\.010326292141839685\ \(0\)\
\-\ fluid\\:\\ 0\\.010247422382294738\ \(0\)\
\-\ all\\:\\ 0\\.010197989406883082\ \(0\)\
\-\ trauma\\:\\ 0\\.00986079654750181\ \(0\)\
\-\ if\\:\\ 0\\.009783727568694663\ \(0\)\
\-\ cell\\:\\ 0\\.00973941228515395\ \(0\)\
\-\ significant\\:\\ 0\\.009695557599384909\ \(0\)\
\-\ \\:\\:\\ 0\\.009538184101187046\ \(0\)\
\-\ fracture\\:\\ 0\\.009506642743766999\ \(0\)\
\-\ prior\\:\\ 0\\.009257859798322207\ \(0\)\
\-\ \\,\\:\\ 0\\.009137892506912654\ \(0\)\
\-\ soft\\:\\ 0\\.008780281704614134\ \(0\)\
\-\ upper\\:\\ 0\\.008700761626028347\ \(0\)\
\-\ \\;\\:\\ 0\\.008546080963934994\ \(0\)\
\-\ tissue\\:\\ 0\\.008546080963934994\ \(0\)\
\-\ most\\:\\ 0\\.008324198910245046\ \(0\)\
\-\ other\\:\\ 0\\.008310711175959698\ \(0\)\
\-\ left\\:\\ 0\\.008068398896817845\ \(0\)\
\-\ 2\\:\\ 0\\.0077641539937153845\ \(0\)\
\-\ after\\:\\ 0\\.007459920686114778\ \(0\)\
\-\ female\\:\\ 0\\.007412490596826302\ \(0\)\
\-\ that\\:\\ 0\\.0062277667871680304\ \(0\)\
\-\ for\\:\\ 0\\.006152811380951182\ \(0\)\
\-\ normal\\:\\ 0\\.0056523732261565445\ \(0\)\
\-\ to\\:\\ 0\\.00540592542332894\ \(0\)\
\-\ history\\:\\ 0\\.004979808175979254\ \(0\)\
\-\ is\\:\\ 0\\.004745069859786713\ \(0\)\
\-\ the\\:\\ 0\\.004666642521641376\ \(0\)\
\-\ pain\\:\\ 0\\.004403409989581159\ \(0\)\
\-\ year\\:\\ 0\\.0040341994484089224\ \(0\)\
\-\ right\\:\\ 0\\.0038043532029975384\ \(0\)\
\-\ old\\:\\ 0\\.003691707159756348\ \(0\)\
\-\ no\\:\\ 0\\.0036305660367249026\ \(0\)\
\-\ of\\:\\ 0\\.0029494633113414793\ \(0\)\
\-\ with\\:\\ 0\\.0024684425335419775\ \(0\)\
\-\ \\.\\:\\ 0\\.0022468060821105237\ \(0\)\
\-\ in\\:\\ 0\\.0017780473845580376\ \(0\)\
\-\ a\\:\\ 0\\.0016734168853105537\ \(0\)\
